Phase I trial of dose escalation with growth factor support in patients with previously untreated diffuse aggressive lymphomas: determination of the maximum-tolerated dose of ProMACE-CytaBOM.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples